These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35576991)

  • 21. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice.
    Dutka T; Hallberg D; Reeves RH
    Mech Dev; 2015 Feb; 135():68-80. PubMed ID: 25511459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
    Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
    Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.
    Canzonetta C; Mulligan C; Deutsch S; Ruf S; O'Doherty A; Lyle R; Borel C; Lin-Marq N; Delom F; Groet J; Schnappauf F; De Vita S; Averill S; Priestley JV; Martin JE; Shipley J; Denyer G; Epstein CJ; Fillat C; Estivill X; Tybulewicz VL; Fisher EM; Antonarakis SE; Nizetic D
    Am J Hum Genet; 2008 Sep; 83(3):388-400. PubMed ID: 18771760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.
    García-Cerro S; Vidal V; Lantigua S; Berciano MT; Lafarga M; Ramos-Cabrer P; Padro D; Rueda N; Martínez-Cué C
    Neurobiol Dis; 2018 Feb; 110():206-217. PubMed ID: 29221819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations.
    Fatemi SH; Otte ED; Folsom TD; Eschenlauer AC; Roper RJ; Aman JW; Thuras PD
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
    Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
    Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice.
    Goodlett CR; Stringer M; LaCombe J; Patel R; Wallace JM; Roper RJ
    Sci Rep; 2020 Jun; 10(1):10426. PubMed ID: 32591597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.
    Blazek JD; Gaddy A; Meyer R; Roper RJ; Li J
    Bone; 2011 Feb; 48(2):275-80. PubMed ID: 20870049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome.
    Laguna A; Barallobre MJ; Marchena MÁ; Mateus C; Ramírez E; Martínez-Cue C; Delabar JM; Castelo-Branco M; de la Villa P; Arbonés ML
    Hum Mol Genet; 2013 Jul; 22(14):2775-84. PubMed ID: 23512985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of Down syndrome: gene content and consequences.
    Gupta M; Dhanasekaran AR; Gardiner KJ
    Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
    Blazek JD; Billingsley CN; Newbauer A; Roper RJ
    Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates.
    Gao FJ; Klinedinst D; Fernandez FX; Cheng B; Savonenko A; Devenney B; Li Y; Wu D; Pomper MG; Reeves RH
    Acta Neuropathol Commun; 2021 Aug; 9(1):137. PubMed ID: 34399854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.
    Siddiqui A; Lacroix T; Stasko MR; Scott-McKean JJ; Costa AC; Gardiner KJ
    Genes Brain Behav; 2008 Oct; 7(7):810-20. PubMed ID: 19125866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals.
    Kida E; Walus M; Jarząbek K; Palminiello S; Albertini G; Rabe A; Hwang YW; Golabek AA
    Neuroscience; 2011 Nov; 195():112-27. PubMed ID: 21878370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.